Treatment of severe acute necrotizing encephalopathy of childhood with interleukin-6 receptor blockade in the first 24 h as add-on immunotherapy shows favorable long-term outcome at 2 years
Patrick H Hosie, Carylyn Lim, Timothy R D Scott, Michael Cardamone, Michelle A. Farrar, Catherine Frith, P. Ian Andrews, Jason Pinner, Sekhar Pillai
Topics & Concepts
MedicineTocilizumabMethylprednisoloneEncephalopathyModified Rankin ScaleInternal medicinePediatricsDiseaseIschemic strokeIschemiaInfectious Encephalopathies and EncephalitisPolyomavirus and related diseasesLong-Term Effects of COVID-19